 Diffusion Pharmaceuticals is currently investigating the use of trans sodium crocetinate in the treatment of COVID-19, acute stroke, and solid cancerous tumors.Oxygen diffusion-enhancing compounds are thought to act by exerting hydrophobic forces that interact with water molecules.These interactions result in greater hydrogen bonding among water molecules, which constitute the majority of the blood plasma medium.